The REPRISE project: protocol for an evaluation of REProducibility and Replicability In Syntheses of Evidence

Overview of attention for article published in Systematic Reviews, April 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

policy: 1 policy source

twitter: 68 X users

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 31 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Dapagliflozin for Chronic Kidney Disease

Cited by Canadian Agency for Drugs and Technologies in Health on 06 Jun 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Melatonin for the Treatment or Prevention of Delirium

Cited by Canadian Agency for Drugs and Technologies in Health on 12 May 2022

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.